News and stories about the UNC Breast Center
A study led by Katherine Reeder-Hayes, MD, MBA, MS, found that Black patients and patients living in certain regions experience greater delays.
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
Researchers developed three different computer models to predict how a hypothetical set of patients with specific types of metastatic breast cancer would respond to different sequences and types of chemotherapy.
A study by Sarah J. Nyante, PhD, MSPH, and colleagues found that the rate of diagnostic accuracy is highest in non‐Hispanic white women and lowest in Hispanic women.
Stephen Hursting, PhD, MPH, and colleagues shared their research findings on nutrition, metabolism and obesity and cancer at the 2022 American Association of Cancer Research meeting.
UNC Lineberger’s Susana Garcia-Recio, PhD, and colleagues have identified molecular features responsible for the development and progression of metastatic breast cancer.
Paul Dayton, PhD, the William R. Kenan Distinguished Professor of Biomedical Engineering, has been named chair of the Joint UNC-NCSU Department of Biomedical Engineering.
View all program news